Company news: Gilead and Janssen
Gilead filed NDAs for two new HIV-infection fighters, while Janssen submitted an NDA for its new TB drug bedaquiline.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.